Splenic Neoplasm — Trials

Splenic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

170 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–10 of 10 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04795869	Brentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell Lymphoma	withdrawn	Phase 2	0	Northwestern UniversityOTHER	1	Oct 10, 2023	clinicaltrials
NCT04639843	Doxorubicin, CC-(486) (5-azacitidine), Romidepsin, and Duvelisib (hARD) for T-cell Lymphoma	withdrawn	Phase 1	0	National Cancer Institute (NCI)NIH	1	Nov 4, 2022	clinicaltrials